The role of microbiota in health and diseases is being highlighted by numerous studies since its discovery. Then, we highlight the pathogenesis of microbiota dysbiosis in disease development and progression, primarily associated with dysregulation of community composition, modulation of host immune response, and induction of chronic inflammation.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Apr 23, 2022 |
| Journal | Signal Transduction and Targeted Therapy |
| Authors | Kejun Hou, Zhuo‐Xun Wu, Xuan-Yu Chen, Jing‐Quan Wang, Dongya Zhang |
| DOI | 10.1038/s41392-022-00974-4 |
| Citations | 2,939 |
| Source | OpenAlex |